all report title image

U.S. UREA CYCLE DISORDERS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

U.S. Urea Cycle Disorders Treatment Market, By Treatment Type (Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, and Others), By Enzyme Deficiency Type (OTC – Ornithine Transcarbamylase, AS – Argininosuccinate Synthetase (citrullinemia), AG – Arginase, AL – Argininosuccinate Lyase, CPS1 – Carbamoyl Phosphate Synthase and NAGS – N-acetylglutamate Synthase), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)-

  • Published In: 25 Mar, 2025
  • Code: CMI5594
  • Page number: 155
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Treatment Type
      • Market Snapshot, By Enzyme Deficiency Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Treatment Landscape
    • Strategic Partnership And Agreement
    • Pipeline Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • Epidemiology
    • Therapeutics Overview
    • Product/Brand Analysis
    • Urea Cycle Disorder (UCD) Treatment Competitive Overview
    • Urea Cycle Disorder (UCD) Patient Journey
  4. U.S. Urea Cycle Disorders Treatment Market, By Treatment Type, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Amino Acid Supplements
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Sodium Phenylbutyrate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Glycerol Phenylbutyrate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Sodium Benzoate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
  5. S. Urea Cycle Disorders Treatment Market, By Enzyme Deficiency Type, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • OTC – Ornithine Transcarbamylase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • AS – Argininosuccinate Synthetase (citrullinemia)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • AG – Arginase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • AL – Argininosuccinate Lyase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • CPS1 – Carbamoyl Phosphate Synthase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • NAGS – N-acetylglutamate Synthase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
  6. U.S. Urea Cycle Disorders Treatment Market, By Route of Administration, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
  7. U.S. Urea Cycle Disorders Treatment Market, By Distribution Channel, 2021–2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033,(US$ Mn)
  8. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
      • Horizon Therapeutics Plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Bausch Health Companies Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Recordati Rare Diseases Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Nestlé S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Danone S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Lucane Pharma SA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Acer Therapeutics Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Ultragenyx Pharmaceutical Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aeglea Biotherapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Arcturus Therapeutics Holdings Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Orpharma Pty Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Selecta Biosciences, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Abbott
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Mead Johnson & Company, LLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
  9. Section

    • Research Methodology
    • About us

*Browse 13 market data tables and 24 figures on "U.S. Urea Cycle Disorders Treatment Market” - Forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.